Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) Sees Significant Decrease in Short Interest

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX – Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 3,284,467 shares, a decrease of 60.0% from the May 31st total of 8,218,482 shares. Based on an average trading volume of 29,919,935 shares, the days-to-cover ratio is currently 0.1 days. Approximately 12.9% of the company’s stock are sold short.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on QTEX shares. Weiss Ratings began coverage on Inspira Technologies OXY B.H.N. in a report on Wednesday, May 27th. They issued a “sell (e+)” rating for the company. Wall Street Zen upgraded shares of Inspira Technologies OXY B.H.N. to a “hold” rating in a report on Saturday, June 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Get Inspira Technologies OXY B.H.N. alerts:

View Our Latest Stock Analysis on QTEX

Inspira Technologies OXY B.H.N. Trading Down 6.5%

Shares of QTEX traded down $0.10 during mid-day trading on Tuesday, hitting $1.44. 3,656,066 shares of the company’s stock were exchanged, compared to its average volume of 14,875,109. Inspira Technologies OXY B.H.N. has a fifty-two week low of $0.28 and a fifty-two week high of $3.85. The company has a current ratio of 1.56, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08.

Inspira Technologies OXY B.H.N. declared that its board has initiated a stock buyback program on Monday, June 22nd that allows the company to buyback 2,000,000,000,000 outstanding shares. This buyback authorization allows the company to reacquire up to 5.6% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its stock is undervalued.

Inspira Technologies OXY B.H.N. Company Profile

(Get Free Report)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.

Read More

• Five stocks we like better than Inspira Technologies OXY B.H.N.
• NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
• Amazon Could Be About to Reap the Rewards of a Software Spending Boom
• Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
• AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?

Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.